Consolidated Statements of Changes in Equity - USD ($) $ in Thousands	Total	Total Stockholders’ equity	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit	Operating Partnership unitholders’ non-controlling interests
Beginning balance (in shares) at Dec. 31, 2022			19,555,272
Beginning balance at Dec. 31, 2022	$ 283,711	$ 229,231	$ 195	$ 254,107	$ 7,486	$ (32,557)	$ 54,480
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net proceeds from sale of common stock (in shares)			1,861,407
Net proceeds from sale of common stock	26,560	26,560	$ 19	26,541
Issuance of operating partnership units in connection with acquisition transactions	9,619						9,619
Shares issued upon redemption of operating partnership units (in shares)			405,106
Shares issued upon redemption of operating partnership units	0	6,730	$ 4	6,726			(6,730)
Cash redemption for non-controlling interests	(558)						(558)
Issuance and amortization of equity-based compensation (in shares)			153,006
Issuance and amortization of equity-based compensation	5,802	3,494	$ 1	3,493			2,308
Issuance and amortization under ESPP (in shares)			14,810
Issuance and amortization under ESPP	215	215		215
Restricted stock withholding (in shares)			(29,390)
Restricted stock withholdings	(445)	(445)		(445)
Dividends and distributions	(24,362)	(19,698)				(19,698)	(4,664)
Unrealized loss on derivative instruments	(3,500)	(2,865)			(2,865)		(635)
Net income	4,583	3,709				3,709	874
Reallocation of non-controlling interest	0	(3,369)		(3,369)			3,369
Ending balance (in shares) at Dec. 31, 2023			21,960,211
Ending balance at Dec. 31, 2023	301,625	243,562	$ 219	287,268	4,621	(48,546)	58,063
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net proceeds from sale of common stock (in shares)			1,420,791
Net proceeds from sale of common stock	19,451	19,451	$ 14	19,437
Issuance of operating partnership units in connection with acquisition transactions	9,409						9,409
Shares issued upon redemption of operating partnership units (in shares)			52,778
Shares issued upon redemption of operating partnership units	0	862	$ 1	861			(862)
Issuance and amortization of equity-based compensation (in shares)			118,887
Issuance and amortization of equity-based compensation	6,385	3,314	$ 1	3,313			3,071
Issuance and amortization under ESPP (in shares)			14,049
Issuance and amortization under ESPP	194	194		194
Restricted stock withholding (in shares)			(45,023)
Restricted stock withholdings	(635)	(635)		(635)
Dividends and distributions	(27,987)	(22,261)				(22,261)	(5,726)
Unrealized loss on derivative instruments	735	609			609		126
Net income	8,321	6,596				6,596	1,725
Reallocation of non-controlling interest	0	(407)		(407)			407
Ending balance (in shares) at Dec. 31, 2024			23,521,693
Ending balance at Dec. 31, 2024	$ 317,498	$ 251,285	$ 235	$ 310,031	$ 5,230	$ (64,211)	$ 66,213